Status:
RECRUITING
Effect on Post-operative Pain of Tranexamic Acid Injection During Shoulder Surgery
Lead Sponsor:
Elsan
Conditions:
Shoulder Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Arthroscopic shoulder surgery is a commonly performed minimally invasive surgery in which a camera (an arthroscope) is inserted inside the shoulder joint. This surgery is responsible for moderate to ...
Eligibility Criteria
Inclusion
- 1 - Male or female aged 18 years old or more; 2- Patient requiring shoulder arthroscopy; 3 - Patient affiliated to a social security scheme; 4 - Patient informed on the study and who has signed the informed consent form.
Exclusion
- \- Tranexamic acid contraindications (Hypersensitivity to the active substance or to any of the excipients, Acute venous or arterial thrombosis, Severe renal impairment, History of convulsions);
- \- Pregnant or breastfeeding patient;
- \- Patient under legal protection;
- \- Patient taking part simultaneously to another clinical trial.
Key Trial Info
Start Date :
February 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT05302986
Start Date
February 24 2023
End Date
September 1 2025
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Polyclinique Jean Villar
Bruges, France, France, 33520